Design, synthesis and anti-inflammatory evaluation of 3-amide benzoic acid derivatives as novel P2Y14 receptor antagonists. 2019

Zhenguo Zhang, and Kun Hao, and Hanwen Li, and Ran Lu, and Chunxiao Liu, and Mengze Zhou, and Baiyang Li, and Zibo Meng, and Qinghua Hu, and Cheng Jiang
Jiang Su Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Tongjiaxiang 24, Nanjing, 210009, China; Department of Medicinal Chemistry, China Pharmaceutical University, Tongjiaxiang 24, Nanjing, 210009, China.

The P2Y14 receptor (P2Y14R) plays a key role in the modulation of inflammatory process, but very few classes of antagonists have been reported. A series of 3-amide benzoic acid derivatives were identified as novel and potent P2Y14R antagonists. The most potent antagonist, 16c, showed comparable activity (IC50 = 1.77 nM) to PPTN, the most potent P2Y14R antagonist reported. Compound 16c demonstrated dramatically improved aqueous solubility and excellent metabolic stability in rat and human microsomes. Investigation of the anti-inflammatory effect of 16c was performed in MSU treated THP-1 cells by flow cytometry, Western Blot and immunofluorescence labeling technology, which exhibited that 16c might be a promising candidate for further research.

UI MeSH Term Description Entries
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000577 Amides Organic compounds containing the -CO-NH2 radical. Amides are derived from acids by replacement of -OH by -NH2 or from ammonia by the replacement of H by an acyl group. (From Grant & Hackh's Chemical Dictionary, 5th ed) Amide
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000893 Anti-Inflammatory Agents Substances that reduce or suppress INFLAMMATION. Anti-Inflammatory Agent,Antiinflammatory Agent,Agents, Anti-Inflammatory,Agents, Antiinflammatory,Anti-Inflammatories,Antiinflammatories,Antiinflammatory Agents,Agent, Anti-Inflammatory,Agent, Antiinflammatory,Agents, Anti Inflammatory,Anti Inflammatories,Anti Inflammatory Agent,Anti Inflammatory Agents
D015195 Drug Design The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include PHARMACOKINETICS, dosage analysis, or drug administration analysis. Computer-Aided Drug Design,Computerized Drug Design,Drug Modeling,Pharmaceutical Design,Computer Aided Drug Design,Computer-Aided Drug Designs,Computerized Drug Designs,Design, Pharmaceutical,Drug Design, Computer-Aided,Drug Design, Computerized,Drug Designs,Drug Modelings,Pharmaceutical Designs
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus
D058919 Purinergic P2 Receptor Antagonists Compounds that bind to and block the stimulation of PURINERGIC P2 RECEPTORS. P2 Purinoceptor Antagonists,P2 Purinoceptor Blockers,Purinergic P2 Receptor Blockers,Antagonists, P2 Purinoceptor,Blockers, P2 Purinoceptor,Purinoceptor Antagonists, P2,Purinoceptor Blockers, P2
D062105 Molecular Docking Simulation A computer simulation technique that is used to model the interaction between two molecules. Typically the docking simulation measures the interactions of a small molecule or ligand with a part of a larger molecule such as a protein. Molecular Docking,Molecular Docking Simulations,Molecular Docking Analysis,Analysis, Molecular Docking,Docking Analysis, Molecular,Docking Simulation, Molecular,Docking, Molecular,Molecular Docking Analyses,Molecular Dockings,Simulation, Molecular Docking
D018048 Receptors, Purinergic P2 A class of cell surface receptors for PURINES that prefer ATP or ADP over ADENOSINE. P2 purinergic receptors are widespread in the periphery and in the central and peripheral nervous system. ADP Receptors,ATP Receptors,P2 Purinoceptors,Purinergic P2 Receptors,Receptors, ADP,Receptors, ATP,ADP Receptor,ATP Receptor,P2 Purinoceptor,Receptor, Purinergic P2,P2 Receptor, Purinergic,P2 Receptors, Purinergic,Purinergic P2 Receptor,Purinoceptor, P2,Purinoceptors, P2,Receptor, ADP,Receptor, ATP

Related Publications

Zhenguo Zhang, and Kun Hao, and Hanwen Li, and Ran Lu, and Chunxiao Liu, and Mengze Zhou, and Baiyang Li, and Zibo Meng, and Qinghua Hu, and Cheng Jiang
April 2021, European journal of medicinal chemistry,
Zhenguo Zhang, and Kun Hao, and Hanwen Li, and Ran Lu, and Chunxiao Liu, and Mengze Zhou, and Baiyang Li, and Zibo Meng, and Qinghua Hu, and Cheng Jiang
July 1999, Journal of biochemistry,
Zhenguo Zhang, and Kun Hao, and Hanwen Li, and Ran Lu, and Chunxiao Liu, and Mengze Zhou, and Baiyang Li, and Zibo Meng, and Qinghua Hu, and Cheng Jiang
October 2018, European journal of medicinal chemistry,
Zhenguo Zhang, and Kun Hao, and Hanwen Li, and Ran Lu, and Chunxiao Liu, and Mengze Zhou, and Baiyang Li, and Zibo Meng, and Qinghua Hu, and Cheng Jiang
December 2021, European journal of medicinal chemistry,
Zhenguo Zhang, and Kun Hao, and Hanwen Li, and Ran Lu, and Chunxiao Liu, and Mengze Zhou, and Baiyang Li, and Zibo Meng, and Qinghua Hu, and Cheng Jiang
August 2020, Bioorganic & medicinal chemistry,
Zhenguo Zhang, and Kun Hao, and Hanwen Li, and Ran Lu, and Chunxiao Liu, and Mengze Zhou, and Baiyang Li, and Zibo Meng, and Qinghua Hu, and Cheng Jiang
January 2013, Bioorganic & medicinal chemistry,
Zhenguo Zhang, and Kun Hao, and Hanwen Li, and Ran Lu, and Chunxiao Liu, and Mengze Zhou, and Baiyang Li, and Zibo Meng, and Qinghua Hu, and Cheng Jiang
December 2018, Food chemistry,
Zhenguo Zhang, and Kun Hao, and Hanwen Li, and Ran Lu, and Chunxiao Liu, and Mengze Zhou, and Baiyang Li, and Zibo Meng, and Qinghua Hu, and Cheng Jiang
May 2020, Chemical & pharmaceutical bulletin,
Zhenguo Zhang, and Kun Hao, and Hanwen Li, and Ran Lu, and Chunxiao Liu, and Mengze Zhou, and Baiyang Li, and Zibo Meng, and Qinghua Hu, and Cheng Jiang
January 2022, Frontiers in chemistry,
Zhenguo Zhang, and Kun Hao, and Hanwen Li, and Ran Lu, and Chunxiao Liu, and Mengze Zhou, and Baiyang Li, and Zibo Meng, and Qinghua Hu, and Cheng Jiang
January 2012, Bioorganic & medicinal chemistry,
Copied contents to your clipboard!